China Oncology Biosimilars Market Research Report Forecast 2017-2021
The China Oncology Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Oncology Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Covidien llc (Medtronic)
Johnson & Johnson MEDICAL
Bolton Surgical
Platts & Nisbett
Frankenman International
Changzhou Waston
Jiangsu Qianjing Medical
Changzhou Anker Medical
Changzhou Tongchuang Medical
China Oncology Biosimilars Market: Product Segment Analysis
Type 1
Type 2
Type 3
China Oncology Biosimilars Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Covidien llc (Medtronic)
Johnson & Johnson MEDICAL
Bolton Surgical
Platts & Nisbett
Frankenman International
Changzhou Waston
Jiangsu Qianjing Medical
Changzhou Anker Medical
Changzhou Tongchuang Medical
China Oncology Biosimilars Market: Product Segment Analysis
Type 1
Type 2
Type 3
China Oncology Biosimilars Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
China Oncology Biosimilars Market Research Report Forecast 2017-2021
CHAPTER 1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Market Segmentation by Type
1.2.1 China Production Market Share of Oncology Biosimilars by Type 1n 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Oncology Biosimilars Market Segmentation by Application
1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Oncology Biosimilars (2012-2021)
CHAPTER 2 CHINA ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Oncology Biosimilars Industry
CHAPTER 3 CHINA ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS
3.1 China Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 China Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA ONCOLOGY BIOSIMILARS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)
4.1 China Oncology Biosimilars Capacity, Production and Growth (2012-2017)
4.2 China Oncology Biosimilars Revenue and Growth (2012-2017)
4.3 China Oncology Biosimilars Production, Consumption, Export and Import (2012-2017)
CHAPTER 5 CHINA ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Oncology Biosimilars Production and Market Share by Type (2012-2017)
5.2 China Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 China Oncology Biosimilars Price by Type (2012-2017)
5.4 China Oncology Biosimilars Production Growth by Type (2012-2017)
CHAPTER 6 CHINA ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
6.1 China Oncology Biosimilars Consumption and Market Share by Application (2012-2017)
6.2 China Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS
7.1 Covidien llc (Medtronic)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Johnson & Johnson MEDICAL
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Bolton Surgical
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 Platts & Nisbett
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Frankenman International
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 Changzhou Waston
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Jiangsu Qianjing Medical
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 Changzhou Anker Medical
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 Changzhou Tongchuang Medical
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
CHAPTER 8 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS
8.1 Oncology Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology Biosimilars
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Oncology Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2021)
12.1 China Oncology Biosimilars Production, Revenue Forecast (2017-2021)
12.2 China Oncology Biosimilars Production, Consumption Forecast by Regions (2017-2021)
12.3 China Oncology Biosimilars Production Forecast by Type (2017-2021)
12.4 China Oncology Biosimilars Consumption Forecast by Application (2017-2021)
12.5 Oncology Biosimilars Price Forecast (2017-2021)
CHAPTER 13 APPENDIX
CHAPTER 1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Market Segmentation by Type
1.2.1 China Production Market Share of Oncology Biosimilars by Type 1n 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Oncology Biosimilars Market Segmentation by Application
1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Oncology Biosimilars (2012-2021)
CHAPTER 2 CHINA ECONOMIC IMPACT ON ONCOLOGY BIOSIMILARS INDUSTRY
2.1 China Macroeconomic Environment Analysis
2.1.1 China Macroeconomic Analysis
2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Oncology Biosimilars Industry
CHAPTER 3 CHINA ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS
3.1 China Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 China Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Oncology Biosimilars Market Competitive Situation and Trends
3.5.1 Oncology Biosimilars Market Concentration Rate
3.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 CHINA ONCOLOGY BIOSIMILARS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)
4.1 China Oncology Biosimilars Capacity, Production and Growth (2012-2017)
4.2 China Oncology Biosimilars Revenue and Growth (2012-2017)
4.3 China Oncology Biosimilars Production, Consumption, Export and Import (2012-2017)
CHAPTER 5 CHINA ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
5.1 China Oncology Biosimilars Production and Market Share by Type (2012-2017)
5.2 China Oncology Biosimilars Revenue and Market Share by Type (2012-2017)
5.3 China Oncology Biosimilars Price by Type (2012-2017)
5.4 China Oncology Biosimilars Production Growth by Type (2012-2017)
CHAPTER 6 CHINA ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION
6.1 China Oncology Biosimilars Consumption and Market Share by Application (2012-2017)
6.2 China Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
CHAPTER 7 CHINA ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS
7.1 Covidien llc (Medtronic)
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Product Type, Application and Specification
7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Business Overview
7.2 Johnson & Johnson MEDICAL
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Product Type, Application and Specification
7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Business Overview
7.3 Bolton Surgical
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Product Type, Application and Specification
7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Business Overview
7.4 Platts & Nisbett
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Product Type, Application and Specification
7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Business Overview
7.5 Frankenman International
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Product Type, Application and Specification
7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Business Overview
7.6 Changzhou Waston
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Product Type, Application and Specification
7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Business Overview
7.7 Jiangsu Qianjing Medical
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Product Type, Application and Specification
7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Business Overview
7.8 Changzhou Anker Medical
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Product Type, Application and Specification
7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Business Overview
7.9 Changzhou Tongchuang Medical
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 Product Type, Application and Specification
7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Business Overview
CHAPTER 8 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS
8.1 Oncology Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology Biosimilars
CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Oncology Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
9.4 Downstream Buyers
CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
CHAPTER 12 CHINA ONCOLOGY BIOSIMILARS MARKET FORECAST (2017-2021)
12.1 China Oncology Biosimilars Production, Revenue Forecast (2017-2021)
12.2 China Oncology Biosimilars Production, Consumption Forecast by Regions (2017-2021)
12.3 China Oncology Biosimilars Production Forecast by Type (2017-2021)
12.4 China Oncology Biosimilars Consumption Forecast by Application (2017-2021)
12.5 Oncology Biosimilars Price Forecast (2017-2021)
CHAPTER 13 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Oncology Biosimilars
Figure China Production Market Share of Oncology Biosimilars by Type 1n 2016
Table Oncology Biosimilars Consumption Market Share by Application in 2016
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Table China Oncology Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table China Oncology Biosimilars Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Oncology Biosimilars Capacity of Key Manufacturers in 2015
Figure China Oncology Biosimilars Capacity of Key Manufacturers in 2016
Table China Oncology Biosimilars Production of Key Manufacturers (2015 and 2016)
Table China Oncology Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Production Share by Manufacturers
Figure 2016 Oncology Biosimilars Production Share by Manufacturers
Table China Oncology Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 China Oncology Biosimilars Revenue Share by Manufacturers
Table China Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Oncology Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Biosimilars Product Type
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Oncology Biosimilars Market Share (2012-2017)
Table Covidien llc (Medtronic) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Covidien llc (Medtronic) Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Covidien llc (Medtronic) Oncology Biosimilars Market Share (2012-2017)
Table Johnson & Johnson MEDICAL Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson MEDICAL Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Market Share (2012-2017)
Table Bolton Surgical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bolton Surgical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Bolton Surgical Oncology Biosimilars Market Share (2012-2017)
Table Platts & Nisbett Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Platts & Nisbett Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Platts & Nisbett Oncology Biosimilars Market Share (2012-2017)
Table Frankenman International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Frankenman International Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Frankenman International Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Waston Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Waston Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Waston Oncology Biosimilars Market Share (2012-2017)
Table Jiangsu Qianjing Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jiangsu Qianjing Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Jiangsu Qianjing Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Anker Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Anker Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Anker Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Tongchuang Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Tongchuang Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Tongchuang Medical Oncology Biosimilars Market Share (2012-2017)
Figure Production Revenue Share of Oncology Biosimilars by Type (2012-2017)
Figure 2015 Revenue Market Share of Oncology Biosimilars by Type
Table China Oncology Biosimilars Price by Type (2012-2017)
Figure China Oncology Biosimilars Production Growth by Type (2012-2017)
Table China Oncology Biosimilars Consumption by Application (2012-2017)
Table China Oncology Biosimilars Consumption Market Share by Application (2012-2017)
Figure China Oncology Biosimilars Consumption Market Share by Application in 2015
Table China Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure China Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure China Oncology Biosimilars Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table China Oncology Biosimilars Production, Import, Export and Consumption Forecast (2017-2021)
Table China Oncology Biosimilars Production Forecast by Type (2017-2021)
Table China Oncology Biosimilars Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
Covidien llc (Medtronic), Johnson & Johnson MEDICAL, Bolton Surgical, Platts & Nisbett, Frankenman International, Changzhou Waston, Jiangsu Qianjing Medical, Changzhou Anker Medical, Changzhou Tongchuang Medical, Jiangsu Reable Medical, Changzhou Resource Medical, Jiangsu Kangjin Medical, Pfizer, Wockhardt
Figure Picture of Oncology Biosimilars
Figure China Production Market Share of Oncology Biosimilars by Type 1n 2016
Table Oncology Biosimilars Consumption Market Share by Application in 2016
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Table China Oncology Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table China Oncology Biosimilars Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Oncology Biosimilars Capacity of Key Manufacturers in 2015
Figure China Oncology Biosimilars Capacity of Key Manufacturers in 2016
Table China Oncology Biosimilars Production of Key Manufacturers (2015 and 2016)
Table China Oncology Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Production Share by Manufacturers
Figure 2016 Oncology Biosimilars Production Share by Manufacturers
Table China Oncology Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 China Oncology Biosimilars Revenue Share by Manufacturers
Table China Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Oncology Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Biosimilars Product Type
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Oncology Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Oncology Biosimilars Market Share (2012-2017)
Table Covidien llc (Medtronic) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Covidien llc (Medtronic) Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Covidien llc (Medtronic) Oncology Biosimilars Market Share (2012-2017)
Table Johnson & Johnson MEDICAL Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson MEDICAL Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson MEDICAL Oncology Biosimilars Market Share (2012-2017)
Table Bolton Surgical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bolton Surgical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Bolton Surgical Oncology Biosimilars Market Share (2012-2017)
Table Platts & Nisbett Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Platts & Nisbett Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Platts & Nisbett Oncology Biosimilars Market Share (2012-2017)
Table Frankenman International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Frankenman International Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Frankenman International Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Waston Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Waston Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Waston Oncology Biosimilars Market Share (2012-2017)
Table Jiangsu Qianjing Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jiangsu Qianjing Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Jiangsu Qianjing Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Anker Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Anker Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Anker Medical Oncology Biosimilars Market Share (2012-2017)
Table Changzhou Tongchuang Medical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Changzhou Tongchuang Medical Oncology Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Changzhou Tongchuang Medical Oncology Biosimilars Market Share (2012-2017)
Figure Production Revenue Share of Oncology Biosimilars by Type (2012-2017)
Figure 2015 Revenue Market Share of Oncology Biosimilars by Type
Table China Oncology Biosimilars Price by Type (2012-2017)
Figure China Oncology Biosimilars Production Growth by Type (2012-2017)
Table China Oncology Biosimilars Consumption by Application (2012-2017)
Table China Oncology Biosimilars Consumption Market Share by Application (2012-2017)
Figure China Oncology Biosimilars Consumption Market Share by Application in 2015
Table China Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure China Oncology Biosimilars Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure China Oncology Biosimilars Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Oncology Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table China Oncology Biosimilars Production, Import, Export and Consumption Forecast (2017-2021)
Table China Oncology Biosimilars Production Forecast by Type (2017-2021)
Table China Oncology Biosimilars Consumption Forecast by Application (2017-2021)
COMPANIES MENTIONED
Covidien llc (Medtronic), Johnson & Johnson MEDICAL, Bolton Surgical, Platts & Nisbett, Frankenman International, Changzhou Waston, Jiangsu Qianjing Medical, Changzhou Anker Medical, Changzhou Tongchuang Medical, Jiangsu Reable Medical, Changzhou Resource Medical, Jiangsu Kangjin Medical, Pfizer, Wockhardt
